James G.Stinehart

Associate

San Diego + 1.858.314.1166

Collegati

Condividi

James Stinehart advises clients on venture, strategic M&A, and private equity deals. His practice focuses on providing corporate counsel to life sciences and technology companies, both public and private, as well as their investors and acquirers.

The clients that James represents include public companies, emerging growth companies in the life sciences and technology sectors, private equity funds, corporate venture capital (CVC) investors, and venture capital funds.

James also works with international clients and Chinese legal counsel on cross-border transactions that require CFIUS (Committee on Foreign Investment in the United States) counseling.

Esperienze

  • Randstad forms joint venture combining its job board business, Monster, with CareerBuilderJones Day advised Randstad N.V., a multinational publicly traded talent company, in connection with the formation of a joint venture combining its job board business, Monster, with CareerBuilder, a subsidiary of investment funds affiliated with Apollo Global Management, Inc.
  • Koch reaches agreement to acquire Wever fertilizer plant from OCI GlobalJones Day advised Koch Ag & Energy Solutions, LLC, an affiliate of Koch Industries, Inc., in the $3.6 billion acquisition of Iowa Fertilizer Company (IFCO) from OCI N.V., a Netherlands-based producer and distributor of hydrogen products.
  • City of Hope invests in Reimagine CareJones Day represented City of Hope in connection with the $25 million Series A financing of Reimagine Care, a technology-driven, home-based cancer care company.
  • Sanken Electric portfolio company receives $175 million investment from Niobrara and Prysm CapitalJones Day advised Sanken Electric Co Ltd. regarding the $175 million investment from Niobrara Capital Partners LP and Prysm Capital LLC as investors in subsidiary Polar Semiconductor LLC.
  • Riverside portfolio company acquires The Lash LoungeJones Day represented The Riverside Company in connection with the acquisition by portfolio company Head to Toe Brands of The Lash Lounge (Lash Lounge), an industry-leading eyelash salon franchise.
  • AURELIUS acquires The Body ShopJones Day advised private equity investor AURELIUS on its acquisition of The Body Shop from Natura & Co S.A.
  • Riverside portfolio company acquires Frenchies Modern Nail CareJones Day represented The Riverside Company in connection with the acquisition by portfolio company Bishops Cuts/Color of Frenchies Modern Nail Care (Frenchies), a nail salon franchisor that provides nail care services with more than 20 locations across 13 states in the U.S.
  • Riverside sells Baker Hill to Flexpoint FordJones Day represented The Riverside Company in connection with the sale of portfolio company Baker Hill, a provider of cloud-based, end-to-end loan origination, risk management, and analytics software, to Flexpoint Ford.
  • Riverside acquires Bishops Cuts/ColorJones Day represented The Riverside Company in connection with the acquisition of Bishops Cuts/Color (Bishops), a franchise company that is a leading provider of hair care services with more than 40 locations across the United States.
  • Accelmed Partners makes $35 million investment in SKNV Inc.Jones Day advised Accelmed Partners in its $35 million investment in SKNV Inc., a full continuum-of-care dermatology digital health company for in-practice dispensing and ecommerce of customized prescriptions and skincare.
    •

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.